ABSTRACT
BACKGROUND
Ayurveda-Traditional Indian system of medicine is becoming increasingly popular nowadays. It is not only a system of medicine but also a science in which the knowledge of living healthy life is imparted and also deals with the knowledge of various sciences pertaining to health. The current Western system of medicine provides treatment to various diseases but many modern medications have side effects and withdrawal symptoms that itself invites others problems. In such circumstances, Ayurveda can be taken into account for an individual needs and their specific disease conditions. Medicinal plants or their preparations play a major role in the prevention, treatment of various diseases as well as improves quality of life with maintenance of health. Their properties and actions are understood thoroughly by ancient acharyas before becoming part of the Ayurvedic pharmacopeia. Among various diseases, bronchial asthma is one among the common diseases in which use of medicinal plants can contribute more in its management, especially in chronic conditions.
Disease Description
Asthma is a common and chronic respiratory disease that affects 1 to 18% of the population in different countries. 1 India has an estimated 15 to 20 million asthmatics.
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Bronchial asthma is a common disorder which is characterized by the inflammation and obstruction of airways. Asthmatics harbor a special type of inflammation in the airways that makes them more responsive than nonasthmatics to a wide range of triggers, leading to excessive narrowing with consequent reduced airflow and symptomatic wheezing and dyspnea. 3 Asthma affects people of all ages but it usually starts in childhood. An extensive description of shwasa roga is present in almost all ayurvedic treatises. Shwasa roga is a disease related to pranavaha srotas 4 and is caused by vitiated vata-kapha dosha which afflicts rasa dhatu and its site of origin is pitta sthana. 5 In ayurvedic perspective, difficulty in breathing or labored breathing is the main cardinal feature of shwasa roga. Among the five types of shwasa roga, clinical features and types of Tamaka shwasa are similar to pattern and associated features found in bronchial asthma. 6 Drugs that alleviate shwasa or difficulty in breathing are Shwasa hara. Shwasa hara drugs and formulation mainly have ushna, kapha-vata shamaka, vatanulomana, and agni-deepana properties. Use of drugs having such properties has also been described in the management of shwasa roga. 7 Acharya charaka has specified a group of 10 drugs that have shwasahara property. 8 There is an extensive description of various herb or plant that bears shwasahara property and which are also useful in Tamaka shwasa.
Flower juice of shirisha is also described in the treatment of shwasa roga associated with vitiated kapha-pitta dosha. 15 .0 to 25.0 cm × 307 to 4.3 cm, flat, thin, form, straw-colored and 6 to 10 seeded with brown spots and depressions alternately on either side over the seeds. 10 Distribution and Habitat: The tree occurs wild in the sub-Himalayan tract in North India and valleys in western and southern India. It is also grown as avenue tree throughout India. 11 It is quite commonly seen in all parts of India, usually planted, tropical, and subtropical regions of Asia and Africa. It is native to deciduous forests in Asia from eastern Pakistan through India and Sri Lanka to Burma. It is cultivated in farmlands, along roadsides, on irrigated plantations, along rivers and as an ornamental plant in gardens due to its pleasant appearance. Compositional studies indicated carbohydrates as major components while saponin was found as a major antinutrient in both pods and seeds. The amino acid profile indicated that arginine and lysine are present in excessive amounts in seeds, while glutamic acid and aspartic acid are present in the highest concentrations in pods. While the linoleic acid was detected as the major fatty acid in pod and seed oil, α-tocopherol was determined as the major tocopherol component in oil.
Ayurvedic properties:
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The guna or properties of shirisha in Ayurveda are described in Table 1 .
Karmas:
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The karmas or therapeutic action of shirisha in Ayurveda are as follows: Shothahara (relieves inflammation) Vranahara (ensures quick wound healing) Vishapaha (useful in treating poisoning) Varnya (good for skin, improves complexion) Twak Doshahara (detoxifies skin and useful in skin diseases) 
RESULTS
Research studies on shirisha with special reference to its antiasthmatic action are as follows. Antioxidant activity: Study of A. lebbeck revealed the IC50 values 240, 100, 160, and 135 µg/mL for DPPH scavenging, deoxyribose degradation, nitric oxide, and H 2 O 2 scavenging assays respectively, which were comparable to the IC50 values of standard ascorbic acid. The plant A. lebbeck was found to be a rich source of phyto-constituents having immense antioxidant potential and the leaves as good source for mineral nutrients. 17 Hepatoprotective activity: The methanolic, ethanolic, and acetone seed extracts of A. lebbeck were assessed for their hepatoprotective activity on human liver hepatocellular carcinoma (HepG2) cell line against paracetamol as a liver damage inducing agent. The cell line viability was assessed by 3-(4, 5-dimethyl thiazol-2-yl)-5-diphenyltetrazolium bromide assay. The maximum cells viability of 131.6 ± 9.39% was observed in methanolic seed extract of A. lebbeck (50 µg/mL). 18 Mast cell stabilizing activity: A. lebbeck at different concentrations has got potent mast cell stabilizing property and the IC50 value of A. lebbeck was found to be 85 µg/ mL. This inhibitory potential of catechin from A. lebbeck is perhaps due to modulation of two important effector's functions, histamine release, and cytokine expression of antigen-immunoglobulin E (IgE)-activated mast cells.
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In vivo Studies
Antiasthmatic activity: Decoction of shirisha bark has shown partial protection of guinea pigs against bronchospasm induced by acetylcholine and histamine. 20 Decoction made from the bark of shirish in the dose of 40 mL per day was given in 30 asthmatic patients along with shatyadi choorna. Significant relief in different parameters like 51.80% improvement in shwasakasta (dyspnea), 62.24% improvement in ghurghur shabda (wheezing), 53.29% improvement in peenas (coryza), 44.20% improvement in forced expiratory volume 1, 34% improvement in peak expiratory flow rate (PEFR), and 46.54% improvement in absolute eosinophil count. 21 Immunomodulatory effect: The hot aqueous extract and butanolic fraction of A. lebbeck bark were administered once daily for 1 week in mice immunized previously with sheep red blood cells. At the dose levels tested (6.25, 12.5, and 25 mg/kg, p.o.), A. lebbeck treated mice developed higher serum antibody titers compared with the vehicle treated group, and the effect was comparable to the standard drug muramyl dipeptide (MDP). 22 Antiinflammatory activity: The petroleum ether and ethanol extracts of A. lebbeck at 400 mg/kg showed maximum inhibition of inflammation induced by carrageenan (petroleum ether-48.6%; ethanol-59.57%), dextran (petroleum ether-45.99%; ethanol-52.93%), cotton pellet (petroleum ether-34.46%; ethanol-53.57%), and Freund's adjuvant (petroleum ether-64.97%; ethanol-68.57%). 23 Antihistaminic activity: Histological analysis of the lungs of guinea pigs treated with Shirisha has shown reduction in tissue edema, epithelial cell hypertrophy, infiltration of inflammatory cell, and airway lumen plugging, thereby decreasing inflammation and bronchoconstriction, which leads to normal lumen size. 24 Pulmonary eosinophilia: Preliminary screening in 35 cases of tropical pulmonary eosinophilia treated with extracts of Shirisha pushpa in a dose of 200 mg twice a day with water indicated 82% marked response, 12% good response, and 6% poor response. No adverse effects were reported in the study.
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Research Studies on Antiasthmatic Effect of Ayurvedic Formulation having Shirisha
• Ayurvedic nebulizing fluid: An Ayurvedic nebulizing fluid had been assessed which contains 50 parts of aqueous extract of stem bark/leaves of shirisha. The result revealed that stem bark aqueous extract showed the best antihistaminic and antitussive activity.
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• Shirishavleha: Comparative analysis of shirishavleha prepared separately from bark and heartwood groups showed good outcome in diminution of symptoms of Tamaka Shwasa along with statistical significance of objective parameters like absolute eosinophil count, PEFR, erythrocyte sedimentation rate, and total leukocyte count.
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• Shirishadi kashaya: This formulation has shown good results in reducing the frequency and severity of bronchial asthma along with significant changes in PEFR. 28 • Shirisharista: A comparative clinical study on shirisharista prepared from bark, sapwood, and heartwood (sara) of A. lebbeck has been assessed for antiasthmatic activity. This study was conducted over 41 patients and it is observed pharmacologically that shirisharista prepared from sara shows significant antiinflammatory, antitussive actions, and significant increase in antihistaminic activity.
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• Shirishadi compound: Extract of Shirishadi compound (containing shirish, nagarmotha, and kantkari in equal parts) is taken for nebulization in the dosage of 2.5 mg (2.5 mL) twice in a day for first 15 days and then si opus sit, followed by oral administration of Shirishadi Ghana Vati-500 mg with lukewarm water, twice in a day for 1 month has been given in 20 patients of bronchial asthma. This formulation has shown significant antiasthmatic activity and improvement is seen in parameters like dyspnea, cough, wheezing, PEFR, forced vital capacity.
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DISCUSSION
Airway inflammation and remodeling are the important pathological events that take place in bronchial asthma.
There are numerous cells like mast cells, basophils, eosinophils, and inflammatory mediators like histamine, cytokines, leukotrienes, IgE that are involved in the pathogenesis of asthma. Because of its antiinflammatory action, shirisha has a significant role in reducing inflammation of the airways. As shirish has mast cell stabilizing activity and antihistaminic activity, it significantly reduces the allergic response of atopic patients and reduces the severity and duration of acute episodes of asthma. Having a good immunomodulatory property, shirisha checks the occurrence of secondary infection in asthmatic patients. It also performs bronchodilating action and relieves bronchospasm. In Ayurveda perspective, digestion plays an important role in the pathogenesis of tamaka shwasa vis-à-vis bronchial asthma. It is also mentioned that the site of origin of shwasa roga is pitta sthana. Thus, hepatoprotective activity of shirisha plays an important role in contravening the pathology of shwasa roga.
CONCLUSION
Shirisha (A. lebbeck) is a very essential medicinal plant described in our traditional system. Despite its uses in various disease conditions, shirisha has very effective antiasthmatic action. Several research studies (both in vitro and in vivo) have been done that establish the antiasthmatic, antiinflammatory, antihistaminic etc. activity effect of shirisha. Classical Ayurvedic formulations, like shirishavleha, shirishadi kwatha, etc., also signify its importance in the treatment of bronchial asthma. It is concluded that shirish (A. lebbeck) is a very competent medicinal plant that can be used as a single herb or in formulation, in the management of bronchial asthma.
CLINICAL SIGNIFICANCE
Bronchial asthma is a prevalent respiratory disorder seen in childhood to elderly people. Use of corticosteroids and bronchodilators in orally or through inhalers are the common medications of asthmatics. Shirish is an excellent Medicinal plants that possesses promising bronchodilation, antiinflammatory, and antiasthmatic activity. Shirisha can be used as a single herb or in compound formulation in asthmatic patients. Including such kind of medicinal plants can minimize the dependency on inhalers, reduces the frequency as well as duration of acute or chronic cases of asthma.
